Women's Health Group Pitches $20 Billion, 10-Year Federal Research Plan. No Bill Exists Yet.

The Society for Women's Health Research (SWHR) wants the federal government to spend $20 billion over the next 10 years fixing what its CEO calls a "diagnostic odyssey" for women in the American healthcare system. That's the headline number from an interview SWHR President and CEO Katie Schubert gave to CBS News, published September 30, 2026 on the network's Healthful segment.

The pitch is real. The funding is not. As of now, there is no bill number, no committee sponsor, and no NIH commitment attached to this $20 billion figure. It's a road map SWHR is proposing, not a program Congress has approved or an allocation NIH has agreed to make. Anyone reading this as enacted policy is getting ahead of the facts.

The Numbers Behind the Ask

Schubert's case rests on a few specific data points. She says that in 1989, when SWHR launched, 13% of the National Institutes of Health's budget went to women's health research. Today, according to Schubert, that share is under 10%. That's a claim from the advocacy organization itself, not an independently audited NIH figure, and CBS News did not cite a separate NIH budget breakdown to verify it.

Schubert also cited research from Melinda French Gates' organization, Pivotal, finding that for every dollar spent globally on medical research and innovation, only 5 cents goes to women's health. That's a global figure, not a U.S.-specific one, and it's important to keep that distinction straight before applying it to American budget debates.

One hard data point nobody disputes: it wasn't until 1993 that NIH-funded scientists were required to include women in clinical trials. That's within living memory for most adults and means decades of drug and treatment data were built almost entirely on male physiology.

Menopause, Heart Disease, and the Diagnostic Gap

Schubert pointed to menopause as her clearest example. "Menopause is something that impacts 100% of that 51% of the population," she told CBS News, "and yet we have millions and millions of dollars going into other research" including, she said, trials for men's sexual health medications. She argues cardiovascular disease research in women has similarly lagged, contributing to longer waits for accurate diagnoses.

Those are Schubert's characterizations of where NIH dollars go, not a side-by-side spending comparison independently verified by CBS News or any other outlet in this reporting. The underlying claim that women face longer diagnostic delays for heart disease and menopause-related conditions than men do for comparable symptoms is widely discussed in medical literature, but the specific dollar comparisons here come from SWHR's own framing.

The Training Gap Behind the Research Gap

Schubert's plan isn't just about lab funding. She told CBS News the $20 billion road map would also fund workforce training so doctors understand female-specific health differences. "If you show up to your doctor, they may not have an understanding of how things are different for women than men," she said. That's a fair point regardless of politics. If the underlying research doesn't exist, no amount of continuing education fixes the knowledge gap it creates.

The Racial Disparity Claim

Schubert also argued the plan would help close racial health disparities, saying that "across the board, it does not matter what issue area we are looking at" — inequities show up between women of color and white women. She attributes that partly to historical exclusion of women and minorities from medical research and partly to what she calls a legacy of "systemic racism and sexism."

That's Schubert's assessment, and it's her right to make it. Whether the specific $20 billion plan actually narrows those disparities, as opposed to simply adding research volume, is an open empirical question the interview doesn't resolve. No independent data in this reporting measures projected disparity reduction from the proposal.

What's Actually Missing From the Coverage

CBS News framed this as a novel, "first-of-its-kind" federal proposal without naming a single member of Congress backing it, a specific NIH institute expected to administer it, or a funding mechanism, new appropriation, reallocation, or otherwise. A companion piece from Forever Delmarva republished the same CBS News reporting nearly word for word, adding no additional reporting or sourcing.

What Comes Next

SWHR has put a number and a decade-long horizon on the table. Whether any lawmaker introduces legislation built around it, and whether NIH's own budget priorities shift in response, hasn't happened yet. Until that happens, this is an advocacy group's proposal for how Washington should spend taxpayer money, not a plan already in motion.